Idiopathic pulmonary fibrosis trials in Greece

In Greece 10 Also abroad 111

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Athens, Chaïdári, Heraklion, Ioannina, Patras, Thessaloniki
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Alexandroupoli, Athens, Chaïdári, Heraklion, Ioannina, Patras, Thessaloniki
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 3Not yet taking people in Greece
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Heraklion, Ioannina, Larissa, Maroussi, Patras
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Athens, Heraklion, Ioannina, Pátrai, Thessaloniki
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Alexandroupoli, Athens, Chaïdári, Heraklion, Patra, Thessaloniki
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Athens, Corfu, Ioannina, Larissa, Maroussi, Patras, Thessaloniki
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Athens, Corfu, Heraklion, Ioannina, Larissa, Maroussi, Patras, Thessaloniki
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Athens, Corfu, Heraklion, Ioannina, Patras, Thessaloniki
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
Phase 3Taking people
Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Where
Pátrai
Age
18 years and over
People
196
Run by
Argyrios Tzouvelekis
See details and how to joinNCT07299695
No phaseTaking people
Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
Where
Heraklion
Age
18 years and over
People
100
Run by
Katerina M. Antoniou
See details and how to joinNCT07466420